BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18083781)

  • 1. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.
    Cherney DZ; Miller JA; Scholey JW; Bradley TJ; Slorach C; Curtis JR; Dekker MG; Nasrallah R; Hébert RL; Sochett EB
    Diabetes; 2008 Mar; 57(3):688-95. PubMed ID: 18083781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.
    Cherney DZ; Scholey JW; Nasrallah R; Dekker MG; Slorach C; Bradley TJ; Hébert RL; Sochett EB; Miller JA
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1336-41. PubMed ID: 18400871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
    Sochett EB; Cherney DZ; Curtis JR; Dekker MG; Scholey JW; Miller JA
    J Am Soc Nephrol; 2006 Jun; 17(6):1703-9. PubMed ID: 16672313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes.
    Cherney DZ; Miller JA; Scholey JW; Nasrallah R; Hébert RL; Dekker MG; Slorach C; Sochett EB; Bradley TJ
    Diabetes Care; 2010 Jun; 33(6):1344-6. PubMed ID: 20332349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
    Cherney DZ; Perkins BA; Soleymanlou N; Maione M; Lai V; Lee A; Fagan NM; Woerle HJ; Johansen OE; Broedl UC; von Eynatten M
    Circulation; 2014 Feb; 129(5):587-97. PubMed ID: 24334175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
    Nasrallah R; Robertson SJ; Hébert RL
    Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.
    Cherney DZ; Sochett EB; Miller JA
    Kidney Int; 2005 Oct; 68(4):1722-8. PubMed ID: 16164648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hyperfiltration is associated with glucose-dependent changes in fractional excretion of sodium in patients with uncomplicated type 1 diabetes.
    Yang GK; Har RL; Lytvyn Y; Yip P; Cherney DZ
    Diabetes Care; 2014 Oct; 37(10):2774-81. PubMed ID: 25011944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion.
    Vervoort G; Veldman B; Berden JH; Smits P; Wetzels JF
    Eur J Clin Invest; 2005 May; 35(5):330-6. PubMed ID: 15860045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.
    Zerbini G; Bonfanti R; Meschi F; Bognetti E; Paesano PL; Gianolli L; Querques M; Maestroni A; Calori G; Del Maschio A; Fazio F; Luzi L; Chiumello G
    Diabetes; 2006 Sep; 55(9):2620-5. PubMed ID: 16936212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S; Johns EJ
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes.
    Perkins BA; Sochett EB; Cherney DZ
    Clin Exp Hypertens; 2012; 34(8):606-11. PubMed ID: 22686422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular haemodynamic profile of patients with Type 1 diabetes compared with healthy control subjects.
    Škrtić M; Lytvyn Y; Yang GK; Yip P; Lai V; Silverman M; Cherney DZ
    Diabet Med; 2015 Jul; 32(7):972-9. PubMed ID: 25662770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of prolonged high protein intake and COX2 inhibition on hypertensive rats with altered renal development.
    Reverte V; Tapia A; Moreno JM; Rodríguez L; Salazar F; Llinás MT; Salazar FJ
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F327-33. PubMed ID: 21613413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.
    Veldman BA; Vervoort G; Blom H; Smits P
    Diabet Med; 2005 Mar; 22(3):301-5. PubMed ID: 15717878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus.
    Yang GK; Maahs DM; Perkins BA; Cherney DZ
    PLoS One; 2013; 8(7):e68908. PubMed ID: 23861950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes.
    Cherney DZ; Sochett EB
    Diabetes Care; 2011 Aug; 34(8):1821-6. PubMed ID: 21636797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit.
    Prévot A; Mosig D; Martini S; Guignard JP
    Pediatr Res; 2004 Feb; 55(2):254-60. PubMed ID: 14605244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
    Schlaich MP; Schmitt D; Ott C; Schmidt BM; Schmieder RE
    J Hypertens; 2008 Jan; 26(1):110-6. PubMed ID: 18090547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.